AnnieJKrugerMDPhD

Gastroenterology • Cambridge, MA

Hepatology & Liver Transplantation

Clinical Research Director, Immunology and Inflammation, Sanofi

Join to view full profile

Dr. Kruger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kruger's full profile

Already have an account?

Office
50 Binney St
Cambridge, MA 02142
Phone+1 617-252-7500

Summary

Dr. Annie Kruger is a Clinical Research Director in Immunology and Inflammation Early Development at Sanofi. She received her medical degree from University of Massachusetts Medical School and completed her residency and fellowship at Massachusetts General Hospital. She was a practicing gastroenterologist and hepatologist at MedStar Georgetown University Hospital prior to joining Sanofi.

Education & Training

Massachusetts General HospitalFellowship, Gastroenterology, 2013 - 2016
Massachusetts General HospitalResidency, Internal Medicine, 2011 - 2014
University of Massachusetts Medical SchoolClass of 2011

Certifications & Licensure

MD State Medical License 2021 - 2026
VA State Medical License 2021 - 2026
DC State Medical License 2018 - 2022
MA State Medical License 2015 - 2020
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology

Publications & Presentations

PubMed

40 citations
Prolonged cenicriviroc therapy reduces hepatic fibrosis despite steatohepatitis in a diet-induced mouse model of nonalcoholic steatohepatitis.
Annie J. Kruger, Bryan C. Fuchs, Ricard Masia, Jacinta A. Holmes, Shadi Salloum
Hepatology Communications. 2018-03-07
25 citations
Combination Therapy with a PI3K/mTOR Dual Inhibitor and Chloroquine Enhances Synergistic Apoptotic Cell Death in Epstein-Barr Virus-Infected Gastric Cancer Cells.
Mi-Young Kim, Annie J. Kruger, Ju-Yeon Jeong, Jaehee Kim, Phil Kyung Shin
Molecules and Cells. 2019-06-30
37 citations
Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection.
Anna Lidofsky, Jacinta A. Holmes, Eoin R. Feeney, Annie J. Kruger, Shadi Salloum
The Journal of Infectious Diseases. 2018-09-22

Journal Articles

Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in HIV/HCV Coinfection
Ma Somsouk, Eoin R Feeney, Raymond T Chung, Steven Deeks, Annie J Kruger, Ricard Masia, Kathleen E Corey, Esperance A Schaefer, The Journal of Infectious Diseases